Latest articles
ABPI responds to General Election result
The ABPI has responded to the General Election result welcoming the news and saying that it is looking forward to working with the new...
Breast cancer blood test could help target treatment
A breast cancer blood test can help identify rare mutations in advanced breast cancer and may enable patients to access effective treatments more quickly...
Janssen presents initial results for BCMA CAR-T therapy
Janssen presents initial results for BCMA CAR-T therapy JNJ-4528 showing early, deep and high responses in the treatment of relapsed or refractory multiple myeloma. The...
Popular articles
Is the NHS a commercially viable market for pharma?
Claudia Rubin, Director at Decideum, questions how long the NHS will be a commercially viable market for pharma as she looks to 2020. “If you...
Does great brand planning make the difference?
As the hot summer days begin to fade behind us, thoughts start to turn towards next year. Teams are ramping up their planning activities...
Janssen presents initial results for BCMA CAR-T therapy
Janssen presents initial results for BCMA CAR-T therapy JNJ-4528 showing early, deep and high responses in the treatment of relapsed or refractory multiple myeloma. The...
How has 2019 shaped community pharmacies?
Deborah Evans, Managing Director of Pharmacy Complete, reflects on how 2019 has shaped the face of community pharmacy. 2019 has been an eventful year for...
Servier and UCL collaborate on immune-inflammatory disease treatments
Accelerating the discovery of new treatments for immune-inflammatory disease, including lupus and systemic sclerosis, is the focus of a new strategic research collaboration between...